Skip to content

Study on the Anti-inflammatory Effect of Huamoyan Granule for Treatment of gouty arthritis with Damp Heat Obstructing Collaterals Syndrome

Study on the Anti-inflammatory Effect of Huamoyan Granule for Treatment of gouty arthritis with Damp Heat Obstructing Collaterals Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INQ-17013681
Enrollment
Unknown
Registered
2017-12-04
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gouty arthritis

Interventions

Group A:Huamoyan Granule, Ibuprofen Sustained Release Capsules
Group B:Ibuprofen Sustained Release Capsules

Sponsors

Shijiazhuang Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) at the same time, it accords with the above western diagnostic criteria and TCM syndrome diagnostic criteria; (2) aged between 18 and 70 years old is at the acute stage of gout, that is, the symptom reaches the peak within 48 hours; (3) no other gouty arthritis drugs are taken at the same time.

Exclusion criteria

Exclusion criteria: (1) serum uric acid level is lower than the normal reference range limit (Shijiazhuang Chinese medicine hospital blood uric acid reference range: 90-430 mol/L); (2) were complicated with other rheumatic diseases, cardiovascular, liver and kidney. The brain, digestive system and hematopoietic system and other serious diseases and mental illness; (3) pregnant or lactating women; (4) advanced arthritis, severe deformity, loss of ability to work in alcohol dependent patients; (5) with the activity of the patients with gastrointestinal diseases, and the research of a month before the digestion ulcer patients; (6) allergy to NSAIDs drugs or traditional Chinese Medicine.

Design outcomes

Primary

MeasureTime frame
VAS pain score;TCM syndrome score;

Secondary

MeasureTime frame
ESR;CRP;IL-1;IL-6;IL-8;

Countries

China

Contacts

Public ContactLiang Hui

Shijiazhuang Hospital of Traditional Chinese Medicine

lianghui1119@163.com+86 13303232189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026